Institut De Cardiologie De Montreal

Montréal, QC

UEI
P741PGTLPY33
CAGE
L6334
Primary NAICS
622310 Specialty (except Psychiatric and Substance Abuse) Hospitals
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Hospital
  • Foreign Government
Entity structure
Country - Foreign Government
SAM.gov registration date
Physical address
5000 Rue Bélanger, Montréal, QC H1T 1C8, Canada

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
Seattle Children's Hospital A total of 840 samples will be analyzed for the various experiments using the following methods by GC-MS and LC-MS. We will also provide assistance for data… R01HL163103 $62,082
Seattle Children's Hospital A total of 840 samples will be analyzed for the various experiments using the following methods by GC-MS and LC-MS. We will also provide assistance for data… R01HL163103 $31,041
The General Hospital Corporation Project summary In the last 15 years, human genetics has identified 1000s of variants that contribute to phenotypic variation, but it remains challenging to… UM1HG012010 $758,672

Similar vendors

About the company

Institut De Cardiologie De Montreal is a hospital in Canada registered to receive federal awards from the U.S. government as a foreign government entity. It has been registered in SAM.gov since 2007 and its registration is active until 2025.

Institut De Cardiologie De Montreal has received sub-awards for federal grants related to cardiovascular and hematological disease research. One project involves characterizing genomic variants associated with these diseases to gain insights into their pathophysiology and develop methods to predict variant and gene causality across complex human diseases. The sub-awards were funded by the National Institutes of Health and the prime grantee was The General Hospital Corporation. Dr. Lettre from Institut De Cardiologie De Montreal is responsible for leading the selection of variants for functional characterization, supervising functional studies of endothelial functions using genome editing and chromatin accessibility assays, and optimizing the generation of polygenic risk scores for heart and blood diseases. Another sub-award involves generating induced pluripotent stem cells from blood or cell lines and converting them to monocytes/macrophages for in vitro studies by the Rioux Laboratory at Institut De Cardiologie De Montreal.

Quick answers

Is Institut De Cardiologie De Montreal registered in SAM.gov?

Yes. Institut De Cardiologie De Montreal's SAM.gov registration is active through October 29, 2026.

What is Institut De Cardiologie De Montreal's most recent federal award?

Institut De Cardiologie De Montreal's most recent federal grant award is University of montreal cardiac surgery clinical investigation group (U01HL088963), from National Institutes of Health, on July 1, 2007.

On GovTribe

See Institut De Cardiologie De Montreal's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors